GENEVA, Sept. 21 -- NANJING ZAIMING PHARMACEUTICAL CO., LTD. (No. 99, Huakang Road, Jiangbei New DistrictNanjing, Jiangsu 210032), 南京再明医药有限公司 (中国江苏省南京市江北新区华康路99号) filed a patent application (PCT/CN2025/082699) for "NITROGEN-CONTAINING WRN INHIBITOR COMPOUND AND USE THEREOF" on Mar 14, 2025. With publication no. WO/2025/190405, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Org...